drugset / Trial / NCT05893108

Ethosomal Gel Bearing Losartan 5% for Keloid Treatment

NCT05893108

RandomizedParallel-groupSingle-blindTreatment

Summary

The objectives are to compare the efficacy of pre and post-treatment and between 5% losartan potassium loaded in ethosomal gel and 10 mg/ml triamcinolone acetonide injection based on the indicator score of The patient and observer scar assessment scale 3.0 (POSAS 3.0), degree of erythema and pigmentation, area size, thickness and density of human keloids.

Timeline

Start
2024-03-30
Primary completion
2024-09-30
Completion
2024-10-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Losartan Other / unclassified 5 % Topical
Comparator Triamcinolone Acetonide Other / unclassified 10 mg/ml Other

Indications